COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials -
COMMUNIQUÉ DE PRESSE
Evotec SE: Invitation to Conference Call
Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. -
-
COMMUNIQUÉ DE PRESSE
Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
-
COMMUNIQUÉ DE PRESSE
Evotec SE to announce results for the first nine months 2023 on 08 November 2023
-
-
-
-
